Our Partners

At the heart of Open Targets is a consortium of complementary partner institutions that bring their respective expertise to collaborative projects that improve how we systematically identify and prioritise drug targets.


News

Study of millions of cells reveals new way to understand genetic risk of disease

3 June 2026

Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease.

Published today (3 June) in Nature, the research carried out at the Wellcome Sanger Institute, Open Targets, and Cambridge University Hospitals NHS Foundation Trust (CUH), identifies the key genetic and cellular drivers of IBD risk and demonstrates the power of single-cell approaches to u...

Read more


Our Principles

A systematic approach

Systematically identify and prioritise the best targets to safely and effectively treat rare and common diseases

Open Exchange of Ideas

We are committed to making our data, methods and results publicly available as soon as possible to foster an open exchange of ideas

Multidisciplinary collaboration

We believe in non-exclusive partnerships that foster the free exchange of ideas, expertise, and data



Designing the Perturbation Catalogue—a UX journey through perturbation data

Adedoyin Okunade, Galabina Yordanova

26 May 2026

Visualising complex data in the Open Targets Platform: our design process for Locus-to-Gene scoring representation

Graham McNeill

19 May 2026

From genetic perturbation to drug safety: Sam Moix’s internship at Open Targets

Samuel Moix

14 May 2026

How the Lotfollahi lab created Tripso to interpret single cell data

Helena Cornu

13 April 2026

Integrating Stem Cell Village Models with the Open Targets Platform for drug target discovery

Trevor Atkeson

9 April 2026

Open Targets Platform 26.03 has been released!

Sir Target

23 March 2026

How we improved Locus-to-Gene scoring representation in the Open Targets Platform

Irene López Santiago

24 February 2026

Introducing the official Open Targets Platform Model Context Protocol

David Ochoa

12 January 2026

Open Targets Platform 25.12 has been released!

Sir Target

10 December 2025

Open Targets Platform 25.09 has been released!

Sir Target

17 September 2025

Why Mallory Freeberg is creating a perturbation catalogue

Helena Cornu

23 July 2025

Case study: an Open Targets Platform MCP server

Helena Cornu

17 July 2025

Open Targets Platform 25.06 has been released!

Sir Target

18 June 2025

An atlas of tissue-specific protein-protein associations helps to prioritise targets for drug discovery

Helena Cornu

6 May 2025

Open Targets Platform 25.03 has been released!

Sir Target

19 March 2025

A step-change in common disease genetics in the Open Targets Platform

David Ochoa

19 March 2025

Case study: gget’s new Open Target module

Helena Cornu

30 January 2025

Open Targets Platform 24.09 has been released!

Sir Target

18 September 2024

Three reflections from David Hulcoop's first year as Executive Director

David Hulcoop

13 August 2024

Tutorial: Introducing the Open Targets Standalone Deployment Tool

Manuel Bernal Llinares

2 July 2024

This website requires cookies and the limited processing of your personal data in order to function.
By using the site, you are agreeing to this as outlined in our Data Protection and Privacy Policy and our Terms of Use Policy.

I agree